Señales en vivo de 002099.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:04):

Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally...

Stats
Volumen de hoy	10.36M
Volumen promedio	14.20M
Capitalización de mercado	10.06B
EPS	CNY0 ( 2023-10-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-20
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-24.38
ATR14	CNY0.0110 (0.17%)

Volumen Correlación

Largo: -0.02 (neutral)

Corto: -0.84 (strong negative)

Signal:(53.065) Neutral

Zhejiang Hisoar Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhejiang Hisoar Correlación - Moneda/Commodity

0.38
( neutral )

0.19
( neutral )

0.00
( neutral )

0.35
( neutral )

0.11
( neutral )

Zhejiang Hisoar Finanzas

Annual	2023
Ingresos:	CNY2.17B
Beneficio Bruto:	CNY304.64M (14.03 %)
EPS:	CNY-0.260

FY	2023
Ingresos:	CNY2.17B
Beneficio Bruto:	CNY304.64M (14.03 %)
EPS:	CNY-0.260

FY	2022
Ingresos:	CNY2.70B
Beneficio Bruto:	CNY720.27M (26.64 %)
EPS:	CNY0.0544

FY	2021
Ingresos:	CNY2.48B
Beneficio Bruto:	CNY925.44M (37.24 %)
EPS:	CNY0.0600

Financial Reports:

No articles found.

Zhejiang Hisoar

Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.